These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

250 related items for PubMed ID: 15814831

  • 1. Low total vitamin C plasma level is a risk factor for cardiovascular morbidity and mortality in hemodialysis patients.
    Deicher R, Ziai F, Bieglmayer C, Schillinger M, Hörl WH.
    J Am Soc Nephrol; 2005 Jun; 16(6):1811-8. PubMed ID: 15814831
    [Abstract] [Full Text] [Related]

  • 2. Homocysteine as a risk factor for cardiovascular disease in patients treated by dialysis: a meta-analysis.
    Heinz J, Kropf S, Luley C, Dierkes J.
    Am J Kidney Dis; 2009 Sep; 54(3):478-89. PubMed ID: 19359080
    [Abstract] [Full Text] [Related]

  • 3. Long-term, low-dose, intravenous vitamin C leads to plasma calcium oxalate supersaturation in hemodialysis patients.
    Canavese C, Petrarulo M, Massarenti P, Berutti S, Fenoglio R, Pauletto D, Lanfranco G, Bergamo D, Sandri L, Marangella M.
    Am J Kidney Dis; 2005 Mar; 45(3):540-9. PubMed ID: 15754276
    [Abstract] [Full Text] [Related]

  • 4. Plasma homocysteine levels and cardiovascular mortality in patients with end-stage renal disease.
    Buccianti G, Baragetti I, Bamonti F, Furiani S, Dorighet V, Patrosso C.
    J Nephrol; 2004 Mar; 17(3):405-10. PubMed ID: 15365961
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Long-term mortality and cardiovascular risk stratification of peritoneal dialysis patients using a combination of inflammation and calcification markers.
    Wang AY, Lam CW, Chan IH, Wang M, Lui SF, Sanderson JE.
    Nephrol Dial Transplant; 2009 Dec; 24(12):3826-33. PubMed ID: 19574337
    [Abstract] [Full Text] [Related]

  • 7. Elevated homocysteine levels in patients with end-stage renal disease.
    Nair AP, Nemirovsky D, Kim M, Geer EB, Farkouh ME, Winston J, Halperin JL, Robbins MJ.
    Mt Sinai J Med; 2005 Nov; 72(6):365-73. PubMed ID: 16358160
    [Abstract] [Full Text] [Related]

  • 8. Serum carboxymethyllysine predicts mortality in hemodialysis patients.
    Wagner Z, Molnár M, Molnár GA, Tamaskó M, Laczy B, Wagner L, Csiky B, Heidland A, Nagy J, Wittmann I.
    Am J Kidney Dis; 2006 Feb; 47(2):294-300. PubMed ID: 16431258
    [Abstract] [Full Text] [Related]

  • 9. Association of carotid intima-medial thickness and indices of arterial stiffness with cardiovascular disease outcomes in CKD.
    Zoungas S, Cameron JD, Kerr PG, Wolfe R, Muske C, McNeil JJ, McGrath BP.
    Am J Kidney Dis; 2007 Oct; 50(4):622-30. PubMed ID: 17900462
    [Abstract] [Full Text] [Related]

  • 10. History of acute coronary events during the predialysis phase of chronic kidney disease is a strong risk factor for major adverse cardiac events in patients initiating haemodialysis.
    Tanaka Y, Joki N, Hase H.
    Nephrol Dial Transplant; 2007 Oct; 22(10):2917-23. PubMed ID: 17644817
    [Abstract] [Full Text] [Related]

  • 11. Oxidized low-density lipoprotein biomarkers in patients with end-stage renal failure: acute effects of hemodialysis.
    Bossola M, Tazza L, Merki E, Giungi S, Luciani G, Miller ER, Lin EB, Tortorelli A, Tsimikas S.
    Blood Purif; 2007 Oct; 25(5-6):457-65. PubMed ID: 18075247
    [Abstract] [Full Text] [Related]

  • 12. High lipoprotein(a) levels and small apolipoprotein(a) size prospectively predict cardiovascular events in dialysis patients.
    Longenecker JC, Klag MJ, Marcovina SM, Liu YM, Jaar BG, Powe NR, Fink NE, Levey AS, Coresh J.
    J Am Soc Nephrol; 2005 Jun; 16(6):1794-802. PubMed ID: 15800123
    [Abstract] [Full Text] [Related]

  • 13. Soluble CD154 is a unique predictor of nonfatal and fatal atherothrombotic events in patients who have end-stage renal disease and are on hemodialysis.
    Hocher B, Liefeldt L, Quaschning T, Kalk P, Ziebig R, Godes M, Relle K, Asmus G, Stasch JP.
    J Am Soc Nephrol; 2007 Apr; 18(4):1323-30. PubMed ID: 17314326
    [Abstract] [Full Text] [Related]

  • 14. 1alpha(OH)D3 One-alpha-hydroxy-cholecalciferol--an active vitamin D analog. Clinical studies on prophylaxis and treatment of secondary hyperparathyroidism in uremic patients on chronic dialysis.
    Brandi L.
    Dan Med Bull; 2008 Nov; 55(4):186-210. PubMed ID: 19232159
    [Abstract] [Full Text] [Related]

  • 15. Malnutrition-inflammation score independently determined cardiovascular and infection risk in peritoneal dialysis patients.
    Ho LC, Wang HH, Chiang CK, Hung KY, Wu KD.
    Blood Purif; 2010 Nov; 29(3):308-16. PubMed ID: 20134162
    [Abstract] [Full Text] [Related]

  • 16. Mineral metabolism and cardiovascular morbidity and mortality risk: peritoneal dialysis patients compared with haemodialysis patients.
    Noordzij M, Korevaar JC, Bos WJ, Boeschoten EW, Dekker FW, Bossuyt PM, Krediet RT.
    Nephrol Dial Transplant; 2006 Sep; 21(9):2513-20. PubMed ID: 16799173
    [Abstract] [Full Text] [Related]

  • 17. Association of LDL cholesterol and inflammation with cardiovascular events and mortality in hemodialysis patients with type 2 diabetes mellitus.
    Krane V, Winkler K, Drechsler C, Lilienthal J, März W, Wanner C, German Diabetes and Dialysis Study Investigators.
    Am J Kidney Dis; 2009 Nov; 54(5):902-11. PubMed ID: 19781835
    [Abstract] [Full Text] [Related]

  • 18. Comorbidity and acute clinical events as determinants of C-reactive protein variation in hemodialysis patients: implications for patient survival.
    Snaedal S, Heimbürger O, Qureshi AR, Danielsson A, Wikström B, Fellström B, Fehrman-Ekholm I, Carrero JJ, Alvestrand A, Stenvinkel P, Bárány P.
    Am J Kidney Dis; 2009 Jun; 53(6):1024-33. PubMed ID: 19394732
    [Abstract] [Full Text] [Related]

  • 19. Plasma osteoprotegerin is associated with mortality in hemodialysis patients.
    Morena M, Terrier N, Jaussent I, Leray-Moragues H, Chalabi L, Rivory JP, Maurice F, Delcourt C, Cristol JP, Canaud B, Dupuy AM.
    J Am Soc Nephrol; 2006 Jan; 17(1):262-70. PubMed ID: 16280472
    [Abstract] [Full Text] [Related]

  • 20. N-terminal pro-brain natriuretic peptide: an independent risk predictor of cardiovascular congestion, mortality, and adverse cardiovascular outcomes in chronic peritoneal dialysis patients.
    Wang AY, Lam CW, Yu CM, Wang M, Chan IH, Zhang Y, Lui SF, Sanderson JE.
    J Am Soc Nephrol; 2007 Jan; 18(1):321-30. PubMed ID: 17167121
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.